These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22442117)

  • 21. Evolution of trace amine associated receptor (TAAR) gene family in vertebrates: lineage-specific expansions and degradations of a second class of vertebrate chemosensory receptors expressed in the olfactory epithelium.
    Hashiguchi Y; Nishida M
    Mol Biol Evol; 2007 Sep; 24(9):2099-107. PubMed ID: 17634392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake and metabolic effects of 3-iodothyronamine in hepatocytes.
    Ghelardoni S; Chiellini G; Frascarelli S; Saba A; Zucchi R
    J Endocrinol; 2014 Apr; 221(1):101-10. PubMed ID: 24627446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T
    Tozzi F; Rutigliano G; Borsò M; Falcicchia C; Zucchi R; Origlia N
    Neurobiol Dis; 2021 Apr; 151():105271. PubMed ID: 33482355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-Iodothyronamine Induces Tail Vasodilation Through Central Action in Male Mice.
    Gachkar S; Oelkrug R; Martinez-Sanchez N; Rial-Pensado E; Warner A; Hoefig CS; López M; Mittag J
    Endocrinology; 2017 Jun; 158(6):1977-1984. PubMed ID: 28368510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulation of Trace Amine-Associated Receptors (TAAR) Expression and Signaling Mode in Melanoma.
    Vaganova AN; Kuvarzin SR; Sycheva AM; Gainetdinov RR
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1.
    Tan ES; Miyakawa M; Bunzow JR; Grandy DK; Scanlan TS
    J Med Chem; 2007 Jun; 50(12):2787-98. PubMed ID: 17497842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.
    Frascarelli S; Ghelardoni S; Chiellini G; Vargiu R; Ronca-Testoni S; Scanlan TS; Grandy DK; Zucchi R
    Eur J Pharmacol; 2008 Jun; 587(1-3):231-6. PubMed ID: 18486124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trace amine-associated receptors and their ligands.
    Zucchi R; Chiellini G; Scanlan TS; Grandy DK
    Br J Pharmacol; 2006 Dec; 149(8):967-78. PubMed ID: 17088868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
    Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
    Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the structure of the trace amine-associated receptor 2: Homology modelling studies exploring the binding mode of 3-iodothyronamine.
    Cichero E; Tonelli M
    Chem Biol Drug Des; 2017 May; 89(5):790-796. PubMed ID: 27863038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of 3-Iodothyronamine and Derivatives in Biological Matrixes: Problems and Pitfalls.
    Lorenzini L; Ghelardoni S; Saba A; Sacripanti G; Chiellini G; Zucchi R
    Thyroid; 2017 Oct; 27(10):1323-1331. PubMed ID: 28859548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.
    Cöster M; Biebermann H; Schöneberg T; Stäubert C
    Eur Thyroid J; 2015 Sep; 4(Suppl 1):9-20. PubMed ID: 26601069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design process.
    Cichero E; Tonelli M
    Future Med Chem; 2017 Sep; 9(13):1507-1527. PubMed ID: 28791911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasodilator Effect of Trace Amines, 3-Iodothyronamine, and RO5263397 in the Rat Perfused Kidney: Comparison with Tryptamine.
    Jragh D; Chandrasekhar B; Yousif MHM; Oriowo MA
    Pharmacology; 2023; 108(4):368-378. PubMed ID: 37245501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of 3-iodothyronamine in vitro dynamics by mathematical modeling.
    Orsi G; Ghelardoni S; Saba A; Zucchi R; Vozzi G
    Cell Biochem Biophys; 2014 Jan; 68(1):37-47. PubMed ID: 23723010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Iodothyronamine-A Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action.
    Köhrle J; Biebermann H
    Endocr Rev; 2019 Apr; 40(2):602-630. PubMed ID: 30649231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Iodothyronamine, a trace amine-associated receptor agonist, regulates intracellular Ca2+ increases via CaMK II through Epac2 in rat cerebral arterioles.
    Sakanoue W; Yokoyama T; Hirakawa M; Maesawa S; Sato K; Saino T
    Biomed Res; 2023; 44(5):219-232. PubMed ID: 37779034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice.
    Manni ME; De Siena G; Saba A; Marchini M; Dicembrini I; Bigagli E; Cinci L; Lodovici M; Chiellini G; Zucchi R; Raimondi L
    Br J Pharmacol; 2012 May; 166(2):650-8. PubMed ID: 22225569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac effects of thyronamines.
    Zucchi R; Ghelardoni S; Chiellini G
    Heart Fail Rev; 2010 Mar; 15(2):171-6. PubMed ID: 19016324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes.
    Schanze N; Jacobi SF; Rijntjes E; Mergler S; Del Olmo M; Hoefig CS; Khajavi N; Lehmphul I; Biebermann H; Mittag J; Köhrle J
    Thyroid; 2017 Jan; 27(1):11-22. PubMed ID: 27788620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.